Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer)

Skip to Content

Clinical Trial Details

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer)

Objective

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). 

IRB Protocol Number
NCT 03851445

Clinical Trial Categories

  • Lung Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6031